CellCarta Forms Global Digital Pathology and AI Consortium

July 16, 2026
CellCarta has launched a Global Digital Pathology and AI Consortium, bringing together several technology partners including Lunit, Mindpeak, Imagene AI, Dipath AI, Nucleai, Tivenix, and Indica Labs to advance biomarker research and digital pathology solutions for biopharma sponsors.

CellCarta has launched its Global Digital Pathology and AI Consortium, announced in a press release. The initiative brings together technology partners including Lunit, Mindpeak, Imagene AI, Dipath AI, Nucleai, Tivenix, and Indica Labs to create a shared ecosystem for AI and digital pathology collaboration.

The consortium aims to give biopharma sponsors access to AI tools and digital pathology workflows for biomarker discovery, patient stratification, and companion diagnostic development. It covers oncology, autoimmune disorders, Alzheimer’s disease, and other indications.

CellCarta said the model is designed to be flexible and AI agnostic, allowing participants to evaluate and deploy multiple AI technologies through one coordinated infrastructure. This approach integrates digital pathology, image analysis, proteomics, genomics, and regulatory capabilities in one system for clinical and translational research programs.

The program will continue to evolve as more partners and technologies are added to support emerging disease areas and new biomarker strategies.

We hope you enjoyed this article.

Consider subscribing to one of our newsletters like Life AI Weekly or Daily AI Brief.

Also, consider following us on social media:

Healthcare & Life Sciences AI AI Brief AI Brief (X)

More from: Life Sciences

07/16
MindWalk Holdings Added to Russell 3000E, Sets Earnings Date for July 22
07/16
Shapiro+Raj Promotes Lisa La Brooy to President
07/16
AgPlenus Launches AI Model for Predicting Antifungal Potency
07/16
IntelePeer Launches Aqurio for AI Automation in Healthcare and Regulated Sectors
07/16
CData Connect AI Extends to HIPAA-Regulated Healthcare Environments

Subscribe to Life AI Weekly

Weekly coverage of AI applications in healthcare, drug development, biotechnology research, and genomics breakthroughs.

AI Token Webinar

Industry analysis

2025 Global Business Services Agenda: Gen AI Takes Center Stage

The Hackett Group

This industry analysis by The Hackett Group explores the transformative impact of generative artificial intelligence (Gen AI) on global business services (GBS) in 2025. The study highlights the shift from exploration to acceleration of Gen AI initiatives, with 89% of executives advancing these projects to improve customer satisfaction, innovate products, and reduce costs. The report also discusses the challenges and strategies for successful Gen AI adoption, emphasizing the need for a technology-enabled operating model and the importance of reskilling the workforce.

Read more

You May Also Like